Sean P. Brusky

Chief Commercial Officer, PARDES BIOSCIENCES, INC.

Companies

Prelude Therapeutics IncChief Business Officer Mar 19, 2026 to now¹
PARDES BIOSCIENCES, INC.Chief Commercial Officer Dec 27, 2021 to Feb 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Prelude Therapeutics Inc PRLD100,000 shares³$337.0K at $3.37Mar 19, 2026
PARDES BIOSCIENCES, INC.21,000 shares⁴Dec 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 8, 2022Bought 21,000 shares at $1.19 of PARDES BIOSCIENCES, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPrelude Therapeutics Inc, Chief Business Officer
2
SEC EDGARPARDES BIOSCIENCES, INC., Chief Commercial Officer
3
SEC EDGARPrelude Therapeutics Inc shares after the filing of Mar 19, 2026
4
SEC EDGARPARDES BIOSCIENCES, INC. shares after the filing of Dec 8, 2022